Successful treatment of MAP2K1 mutant stage IV-M1d melanoma with trametinib plus low-dose dabrafenib: a case report. - Dirven I; Calliauw E; Awada G; Vounckx M; Kessels JI; Neyns B (Frontiers in medicine, 2024)